CustomerValidation
- •CellRep.2017Jun13;19(11):2177-2184.
- •Elife.2015Nov17;4:e08501.
- •JBiolChem.2015Jul17;290(29):17879-93.
- •TechnischenUniversitätMünchen.10.03.2017.
Description | HG-9-91-01isapotentandhighlyselectivesalt-induciblekinase(SIKs)inhibitorwithIC50sof0.92nM,6.6nMand9.6nMforSIK1,SIK2andSIK3respectively. |
---|---|
IC50&Target | IC50:0.92/6.6/9.6nM(SIK1/2/3)[1] |
InVitro | HG-9-91-01inhibitsanumberofproteintyrosinekinasesthatpossessathreonineresidueatthegatekeepersite,suchasSrcfamilymembers(Src,Lck,andYes),BTK,andtheFGFandEphrinreceptors[1].HG-9-91-01demonstratesastrongcorrelationbetweenthepotencyofSIK2inhibitionandenhancedIL-10production.Inagreementwiththesereports,pretreatingBMDCswithHG-9-91-01,arecentlydescribedinhibitorofSIK1-3,alongwithseveralotherkinases,resultsinconcentration-dependentpotentiationofzymosan-inducedIL-10productionwithanEC50~200nMandamaximumeffectsimilartothatobservedwithPGE2[2].HG-9-91-01hasmorethana100-foldgreaterpotencyagainstSIKsthanAMPK(IC50=4.5μM)inacell-freeassay.HG-9-91-01treatmentdosedependentlyincreasedmRNAexpressionofPck1andG6pcandthateffectissimilarincellstreatedwith4μMHG-9-91-01or0.1μMglucagon.Consistentwiththisobservation,thereisalsoadose-dependentincreaseinglucoseproductionfollowingHG-9-91-01treatment[3]. |
References |
|
PreparingStockSolutions |
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent. | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CellAssay [2] | HG-9-91-01isdissolvedinDMSOandstored,andthendilutedwithappropriatemediabeforeuse[2]. BonemarrowisharvestedfromfemursandtibiasofC57BL/6mice.Bone-marrow-deriveddendriticcells(BMDCs)aredifferentiatedDMEMsupplementedwith2mMGlutaMAX,10%(vol/vol)FBS,Penicillin,Streptomycin,and2%mousegranulocyte-macrophagecolony-stimulatingfactor(GM-CSF)-conditionedmediaderivedfrommurineLcells.Culturesaredifferentiatedfor7dandroutinelyanalyzedfor>90%CD11c(allophycocyanin(APC)anti-CD11ccloneHL3)positivitybyflowcytometrybeforeuseinexperiments.Lentiviraltransductionofbonemarrowculturesisconductedbyadditionof293TculturesupernatantscontaininglentiviralparticlesencodingtheCREB-dependentluciferasereporterconstructorCRTC3targetingorcontrolshRNAs1dpostisolation.StableintegrationoflentiviralshRNAconstructsisselectedbyadditionofpuromycin(3μg/mL)onday4posttransduction.After2d,stablytransducedBMDCsarereleasedfromselectionandusedinsubsequentassays.Unlessotherwiseindicated,cellsaretreatedfor2dwithPGE2(5μM)orHG-9-91-01(0.5μM)oranequivalentconcentrationofDMSO(≤0.5%)andthenstimulatedfor18hwithLPS(100ng/mL),R848(10μg/mL),orZymosan(4μg/mL)[2].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly. | ||||||||||||||||
References |
|
MolecularWeight | 567.68 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Formula | C₃₂H₃₇N₇O₃ | ||||||||||||
CASNo. | 1456858-58-4 | ||||||||||||
Storage |
| ||||||||||||
Shipping | RoomtemperatureincontinentalUS;mayvaryelsewhere | ||||||||||||
Solvent&Solubility | 10mMinDMSO HG9-91-01isdissolvedin30%propyleneglycolplus70%ethanol[4]. *"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">1> | ||||||||||||
References |
|
Purity:95.83%